January 27, 2021
Sustainability TopicsNew
Daiichi Sankyo has launched a Breast and Cervical Cancer Screening Camp Project in Nepal in collaboration with AMDA Multisectoral and Integrated Development Services (AMDA-MINDS), a non-governmental, non-profit organization headquartered in Okayama City, Japan.

          
(Training for Female Community Health Volunteer)

In Nepal, the ratio of women receiving breast and cervical cancer screening is low, partly because a periodic screening system for and awareness raising on the prevention of breast and cervical cancers are not well put into place. In many cases, cancer has already progressed to an advanced stage by the time the person gets a cancer screening. Among women, these two cancers are the most common types of cancers, accounting for 30 % of all cancer-related deaths (according to WHO International Agency for Research on Cancer 2020).
In recent years, the Government of Nepal has been working on measures such as the “cervical cancer screening and prevention programs” and “free breast cancer screening.” However, they have not been sufficient enough due to lack of budget and human resources.
Under this project, we will work to increase the number of people who receive cancer screenings and promote early cancer detection by expanding screening services and improving residents’ understanding of breast and cervical cancers through screening camps and awareness-raising activities in the Gokarneshwar Municipality , Kathmandu District.
We believe that this initiative will contribute to the achievement of Goal 3 of the Sustainable Development Goals (SDGs): “Ensure healthy lives and promote well-being for all at all ages.”

            
(Training for staff of healthcare facilities and the local government) (Interview survey with local residents)

<Project Overview>
1. Activities: Organize screening camps, provide screening equipment, technical training for health personnel, and awareness-raising activities
2. Goals: Increase screening opportunities for breast and cervical cancers and promote early cancer detection
3. Period: 3 years (from January 2021 to December 2023)
4. Collaborative partner: AMDA-MINDS

As a pharmaceutical company with a purpose to “contribute to the enrichment of quality of life around the world,” the Daiichi Sankyo Group will work on promoting research and development in the field of global health to create innovative pharmaceuticals on an ongoing basis, and addressing access to healthcare in areas where adequate medical support is not provided.

 < About AMDA-MINDS>
A non-governmental, non-profit organization, headquartered in Okayama City that works to improve people’s living in some developing countries through human resources development and activation of rural communities. It currently implements projects in Asia, Africa, and Latin America where approximately 100 staff members are engaged in social development activities in the field of public health, WASH (water, sanitation and hygiene), improvement of livelihood, agriculture, and youth development. In Japan, it promotes social education through education for international understanding and corporate collaboration. AMDA-MINDS, established in 2007 with Shunsuke Suzuki as Managing Director, is a member organization of the AMDA (Association of Medical Doctors of Asia) Group.
https://www.amda-minds.org/english